Our CFO Quoted in Article on Giving
October 19, 2018
The Lupus Research Alliance Chief Financial Officer Debra Rose is quoted in an article in Consumers Advocate about nonprofits ...
Stories & News
Amanda Greene Advises on Talking About Your Lupus
October 18, 2018
There are few things that a person living with lupus can control. The how and when we...
LRA Distinguished Innovator Wins 2019 Breakthrough Prize
October 17, 2018
Winner of our most substantial grant, the Dr. William E. Paul Distinguished Innovator Awards in Lupus and Autoimmunity, Dr. Zhijian...
Celebrating Lupus Awareness Month
October 15, 2018
“For us, raising awareness about this awful disease isn’t limited to May. All year long, we are...
Serving Under-served Lupus Communities
October 15, 2018
The Lupus Research Alliance’s Multi-cultural Outreach Task Force is out in full force to raise awareness among...
Lupus Patient-Focused Drug Development Meeting
The Lupus Research Alliance collaborated with the Lupus and Allied Diseases Association and the Lupus Foundation of America on...
Patient Involvement: The Next Critical Step
October, 2018
Certainly, advocacy is absolutely necessary to generate funding for the National Institutes of Health (NIH) and other federal organizations,...
Advocacy on the Personal Level
“Advocacy has many forms, including taking action for one’s own health. It’s self-advocacy — even though many would not think...
Advocacy: The Critical First Step
Advocacy can mean different things to different people. Some seek to make changes in policy and funding at state...
Lupus Kidneys Copy Tumors’ Tactic to Protect Themselves
October 4, 2018
Abnormal immune cells invade the kidneys in patients with lupus and can damage the organs so severely...
Cancer Study Shows How Body’s Trash Pickup Fails in Lupus
October 4, 2018
Immune cells called macrophages that normally clear away the body’s trash don’t do their jobs in lupus....
Good News from Aurinia Pharmaceuticals for Lupus Nephritis
September 25, 2018
Congratulations to Aurinia Pharmaceuticals for completing patient enrollment in the AURORA Phase 3 clinical trial ahead of...